Aditxt amends Evofem merger terms, reduces third investment to $720k; effectuates 1-for-40 reverse stock split

Aditxt, Inc.

Amendment No. 3 to Evofem merger: Third investment reduced from $1.5M to $720k, due Oct 2; Fourth increased from $1.5M to $2.28M, due Oct 31.
1-for-40 reverse stock split effective Oct 1, 2024; trading on split-adjusted basis from Oct 2.
On Oct 2, 2024, Aditxt purchased 720 shares of Evofem Series F-1 Preferred for $720k under amended terms.
Evofem waived Aditxt's prior non-compliance with Parent Equity Investment obligations.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Aditxt, Inc.: Certificate of incorporation amended to effect a one-for-forty reverse stock split of common stock (effective 2024-10-01).

Change: charter amendment
Effective: 2024-10-01

Exact text from the filing

On October 1, 2024, the Company filed with the Secretary of State of the State of Delaware a certificate of amendment to its certificate of incorporation (the “Certificate of Amendment”) to effect the Reverse Stock Split.

View on SEC.gov

Browse all governance changes →

Aditxt, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-24-085056

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.